Skip to content
Governance Register

← US public companies

Polaris Venture Partners Entrepreneurs' Fund V, L.P.

SEC-identified person · CIK 1439587 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Invivyd, Inc. IVVD Officer filed 2022 - 2022
Lyra Therapeutics, Inc. LYRA Officer filed 2020 - 2020
Phreesia, Inc. PHR Officer filed 2019 - 2019
Cardlytics, Inc. CDLX Director filed 2018 - 2019
Ruthigen, Inc. RTGN Officer filed 2015 - 2018
X4 Pharmaceuticals, Inc XFOR Officer filed 2017 - 2017
Kala Pharmaceuticals, Inc. KALA Officer filed 2017 - 2017
Selecta Biosciences INC SELB Officer filed 2016 - 2016
T2 Biosystems, Inc. TTOO Officer filed 2014 - 2015
Genocea Biosciences, INC. GNCA Officer filed 2014 - 2015
Atyr Pharma INC LIFE Officer filed 2015 - 2015
Ocular Therapeutix, INC OCUL Officer filed 2014 - 2015
Trevena INC TRVN Officer filed 2014 - 2014
Dare Bioscience, Inc. DARE Officer filed 2014 - 2014
Fate Therapeutics INC fate Officer filed 2013 - 2013
Dnib Unwind, INC. BIND Officer filed 2013 - 2013
Internet Brands, INC. INET Officer filed 2008 - 2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.